Dr. Ahsan Mahmood, MD

Dr. Mahmood practices at Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System.

Dr. Mahmood's NPI, 1760458921, was assigned on February 27, 2006. Dr. Mahmood graduated from Dow University of Health Sciences in 1995. Dr. Mahmood's Indiana license number on file is 01067441A.

Dr. Mahmood's primary practice is Parkview Regional Medical Center, at 11109 Parkview Plaza Drive, Fort Wayne, IN 46845 in Allen County. The practice phone is (260) 266-1195.

Dr. Mahmood's primary practice is Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System. Dr. Mahmood is also affiliated with Parkview Wabash Hospital. The medical group on file is Parkview Physicians Group. Dmand AI also links Dr. Mahmood to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahmood practices, 5 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Mahmood's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Mahmood is board certified in addiction medicine by the American Board of Preventive Medicine. Dmand AI has Dr. Mahmood's licenses on file in 3 states: Indiana, New York and Pennsylvania.

Dmand AI lists psychoses among the conditions Dr. Mahmood treats.

CMS data shows 69 Medicare services from Dr. Mahmood across 2 procedure codes in 2024, all of them office visits, for 51 Medicare patients. Medicare paid $3,884 for them. Every service was in an office.

CMS counts 51 Medicare patients who saw Dr. Mahmood in 2024. The largest group is under 65, with 36 patients. 73% of them have schizophrenia and other psychoses, and 61% have anxiety. 78% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mahmood's median patient age at 53, with 55% women.

In 2024, Dr. Mahmood wrote 1,515 Medicare Part D claims for 163 patients. 84% of them were for generic drugs. CMS names the drug for 1,119 of them, across 33 drugs with 11 or more claims each, at $529,182 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Mahmood for performance year 2024, reported as part of a group. Dr. Mahmood accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Mahmood in 2011. Dr. Mahmood's most frequent co-authors are Adam K. Ashton, MD, Andrew J. Francis, MD and Steven Joel Frucht, MD.

CMS Open Payments shows 181 general payments to Dr. Mahmood from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $2,271.

Dr. Mahmood graduated from Dow University of Health Sciences in 1995. Dr. Mahmood is a member of AAPL and APA.

Dr. Mahmood is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.